Alnylam Pharmaceuticals, Inc.

Report date
9/30/2025
Quarter
2025 Q3
Filed
11/14/2025
Shares
6,197
Value ($000)
2,826
Weight
0.0%
2020 Q4 - 2025 Q3 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).